Samsung Bioepis Gains European Commission (EC) Approval for Denosumab Biosimilar (OBODENCE™, XBRYK™)
Samsung Bioepis Co., Ltd. today announced that the European Commission (EC) has granted marketing authorization for OBODENCE™ (60mg pre-filled syringe) and XBRYK™ (120mg vial), denosumab biosimilars ...
Verywell Health on MSN12mon
Patellofemoral Stress Syndrome: Causes and Treatment of 'Runner's Knee'Adjei, MD Patellofemoral stress syndrome (PFSS), also known as "runner's knee" or "jumper's knee," is a type of overuse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback